![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1744534
¼¼°èÀÇ ¿ì¸£¼Ö»ê ½ÃÀå ¿¹Ãø(-2032³â) : Á¦Ç° À¯Çüº°, ÃßÃ⺰, ¼øµµ ·¹º§º°, Çüź°, ¿ëµµº°, Áö¿ªº° ºÐ¼®Ursolic Acid Market Forecasts to 2032 - Global Analysis By Product Type, Extraction, Purity Level, Form, Application and By Geography |
Stratistics MRC¿¡ µû¸£¸é, ¼¼°èÀÇ ¿ì¸£¼Ö»ê ½ÃÀåÀº 2025³â¿¡ 3¾ï 7,643¸¸ ´Þ·¯¸¦ Â÷ÁöÇϰí, ¿¹Ãø ±â°£ µ¿¾È CAGR 6.9%¸¦ ³ªÅ¸³», 2032³â±îÁö´Â 6¾ï 51¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.
¿ì¸£¼Ö»êÀº »ç°ú, ·ÎÁ¸®, ŸÀÓ, ¹ÙÁú µî ´Ù¾çÇÑ °úÀÏ, Çãºê, ½Ä¹°ÀÇ ¿Î½ºÁú ÄÚÆÃ¿¡¼ ¹ß°ßµÇ´Â õ¿¬ À¯·¡ÀÇ ÈÇÕ¹°ÀÔ´Ï´Ù. ÀÌ ±â´ëµÇ´Â °ÍÀ¸·ÎºÎÅÍ, ¿ì¸£¼Ö»êÀº ÁÖ¸ñ¹Þ°í ÀÖ½À´Ï´Ù. ¶Ç, ½ÉÀåÇ÷°üÀÇ °Ç°À» ¼Æ÷Æ®ÇØ, Áö¹æ ÃàÀûÀ» °¨¼Ò½ÃŰ°í ±ÙÀ°ÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â °¡´É¼º¿¡ ´ëÇØ¼µµ ¿¬±¸°¡ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù.
Frontiers in Pharmacology¿¡ °ÔÀçµÈ Á¾ÇÕÀûÀÎ ¸ÞŸºÐ¼®¿¡ µû¸£¸é, ¿ì¸£¼Ö»ê(UA)Àº IL-1B, IL-6, TNF-a µîÀÇ ¿°Áõ¼º »çÀÌÅäÄ«ÀÎÀ» À¯ÀÇÇÏ°Ô °¨¼Ò½ÃŰ´Â ÇÑÆí, SOD³ª GSHµîÀÇ Ç×»êÈÈ¿¼Ò¸¦ Áõ°ÇÕ´Ï´Ù.
½Ä¹° À¯·¡ÀÇ Ãµ¿¬ ¼ººÐ¿¡ ´ëÇÑ °ü½É Áõ°¡
¿ì¸£¼Ö»ê ½ÃÀåÀº õ¿¬À¸·Î ½Ä¹° À¯·¡ÀÇ Áö¼Ó °¡´ÉÇÑ ¼ººÐÀ» ¿ä±¸ÇÏ´Â ¼¼°èÀÇ µ¿Çâ¿¡ ÀÇÇØ Å©°Ô °ßÀεǰí ÀÖ½À´Ï´Ù. ƯÈ÷ ¼±Áø±¹¿¡¼´Â ½Äǰ, ÈÀåǰ, ¼Çø®¸ÕÆ® Á¦Ç°¿¡ ÀÖ¾î¼ ÇÕ¼º ÈÇй°Áú ´ë½Å¿¡ ½Ä¹° À¯·¡ÀÇ ¼ººÐÀ» ¼±ÅÃÇÏ´Â °æÇâÀÌ °ÇØÁö°í ÀÖ½À´Ï´Ù. ŸÀÓ, Ȧ¸® ¹ÙÁú µîÀÇ Çãºê¿¡ Æ÷ÇԵǴ õ¿¬ À¯·¡ÀÇ Æ®¸®Å׸£Æä³ëÀ̵åÀÎ ¿ì¸£¼Ö»êÀº ÀÌ ¿ä±¸¿¡ ¿Ïº®ÇÏ°Ô ÀÀÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ȯ°æÀÇ Áö¼Ó°¡´É¼ºÀ̳ª ÇÕ¼º ¼ººÐÀÇ Àå±âÀûÀÎ °Ç° ¿µÇâ¿¡ ´ëÇÑ ¿ì·ÁÀÇ °íÁ¶µµ, õ¿¬ À¯·¡ÀÇ ÈÇÕ¹°À» ÁÁ¾ÆÇÏ´Â °æÇâ¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.
ºÒÃæºÐÇÑ ¿ëÇØµµ¿Í ³·Àº »ýüÀÌ¿ë·ü
¿ì¸£¼Ö»êÀÇ Å« ´ÜÁ¡Àº °æ±¸ ¼·Ãë½ÃÀÇ »ý¹°ÇÐÀû ÀÌ¿ë´ÉÀÌ ³·´Ù´Â °ÍÀÔ´Ï´Ù. ȤÀº Ä¡·á¿¡ÀÇ Àû¿ë¿¡´Â º°·Î È¿°ú°¡ ¾ø½À´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇϱâ À§Çؼ, ¸®Æ÷Á», ³ª³ë ÀÔÀÚ, °íü ºÐ»êü µîÀÇ »õ·Î¿î Àü´Þ ¹æ¹ýÀÌ °ËÅäµÇ°í ÀÖ½À´Ï´Ù¸¸, Á¦Á¶ ºñ¿ëÀ̳ª º¹À⼺ÀÌ Áõ°¡Çϱ⠶§¹®¿¡ ÀÌ·¯ÇÑ Á¦Ç°À» ÆÇ¸ÅÇÏ´Â °ÍÀÌ ¾î·Á¿öÁö°í ÀÖ½À´Ï´Ù.
±ÙÀ° °Ç°°ú ½ºÆ÷Ã÷ ¿µ¾çÀÇ ÃÖ±Ù µ¿Çâ
±ÙÀ° ¼ºÀåÀ» °¡¼ÓÇϰí Áö¹æ·®À» °¨¼Ò½ÃŰ´Â ´É·ÂÀÌ ÀÔÁõµÇ¾ú±â ¶§¹®¿¡ ¿ì¸£¼Ö»êÀº ½ºÆ÷Ã÷ ¿µ¾ç°ú Ȱ¼º ¶óÀÌÇÁ ½ºÅ¸ÀÏ Á¦Ç°ÀÇ ÀαⰡ ³ô¾ÆÁö´Â °¡¿îµ¥ Å« ±âȸ¸¦ °®°í ÀÖ½À´Ï´Ù. ¿ì¸£¼Ö»êÀº IGF-1 ½ÅÈ£Àü´ÞÀ» Áõ°¡½ÃŰ°í ±ÙÀ§Ãà°æ·Î¸¦ ¾ïÁ¦ÇÏ´Â °ÍÀÌ ¿¬±¸¿¡¼ ÀÔÁõµÇ¾ú±â ¶§¹®¿¡ ¿îµ¿¼±¼ö, ÇÇÆ®´Ï½º ¾ÖÈ£°¡, ±ÙÀ°·®À» À¯ÁöÇϰíÀÚ ÇÏ´Â ³ëÀÎÃþ¿¡°Ô ¸Å·ÂÀûÀÔ´Ï´Ù. °í°µµ ¿îµ¿°ú ·¹Áö½ºÅϽº ÈÆ·ÃÀ» ÇÏ´Â °í°´µµ ¿ì¸£¼Ö»ê¿¡ ¸Å·ÂÀ» ´À³¥ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿ì¸£¼Ö»êÀº ƯÈ÷ ¹Ì±¹, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼ ¼¼°è ½ºÆ÷Ã÷ ¿µ¾ç ½ÃÀåÀÌ ¼ºÀåÇÔ¿¡ µû¶ó Á¦Á¶¾÷ü°¡ »õ·Î¿î ½Ä¹° À¯·¡ ¼º´É Çâ»ó ¼ººÐÀ¸·Î ÀÚ¸® ¸Å±è ÇÒ ¼ö ÀÖ½À´Ï´Ù.
´Ù¸¥ õ¿¬ ¹°Áú°úÀÇ °·ÂÇÑ °æÀï
·¹½ºº£¶óÆ®·Ñ, Ŀť¹Î, Äɸ£¼¼Æ¾, ³ìÂ÷ Ä«Å×Ų°ú °°Àº Àß ¾Ë·ÁÁø ´Ù¸¥ õ¿¬ »ý¸® Ȱ¼º ¼ººÐ°úÀÇ °æÀïÀº ¿ì¸£¼Ö»ê ½ÃÀåÀÌ Á÷¸éÇÏ´Â °¡Àå Å« À§Çè Áß ÇϳªÀÔ´Ï´Ù. ÀǾàǰ, ¿µ¾ç º¸ÃæÁ¦, ÈÀåǰ »ê¾÷¿¡¼ ÀÌ·¯ÇÑ ¹°ÁúÀº ÀÌ¹Ì ¼ÒºñÀÚÀÇ °ÇÑ ½Å·Ú, °ÇÑ ºê·£µå ÀÎÁöµµ, È®½ÇÇÑ °úÇÐÀû µÞ¹ÞħÀ» ´©¸®°í ÀÖ½À´Ï´Ù. ¶Ç, ¿ì¸£¼Ö»ê¿¡ ºñÇØ, ±ÔÁ¦»óÀÇ ¼ö¿ë¼ºÀÌ ³ô°í, »ý¹°ÇÐÀû ÀÌ¿ë´ÉÀÌ ¶Ù¾î³ °Íµµ ¸¹½À´Ï´Ù. ¶ÇÇÑ Á¦Ç° °³¹ßÀÚ´Â Á¦ÇüÈ ½Ã ÀÌ·¯ÇÑ ´ëü¹°ÁúÀ» ÃÖ¿ì¼±À¸·Î »ý°¢ÇÕ´Ï´Ù. ¿ì¸£¼Ö»ê ½ÃÀå Á¡À¯À²Àº È¿À²¼º, ¾ÈÀü¼º, Àü´Þ ½Ã½ºÅÛ Ãø¸é¿¡¼ ƯÇÊÇØ¾ß ÇÒ µÎµå·¯Áø ÀÌÁ¡À» ³ªÅ¸³»Áö ¾Ê´Â ÇÑ ÀÌ·¯ÇÑ Ä¡¿ÇÑ °æÀï ȯ°æ¿¡ ÀÇÇØ ÀúÇϵ˴ϴÙ.
COVID-19 ÆÒµ¥¹ÍÀº ¿ì¸£¼Ö»ê ½ÃÀå¿¡ ´Ù¾çÇÑ ¿µÇâÀ» ÁÖ¾ú½À´Ï´Ù. ´çÃÊ¿¡´Â ³ëµ¿·Â ºÎÁ·, °ø±Þ üÀÎÀÇ È¥¶õ, ¿ø·á äÃëÀÇ Á¦ÇÑ µî ¶§¹®¿¡ ƯÈ÷ Áß¼Ò Á¦Á¶¾÷ü¿¡ ÀÖ¾î¼ »ý»ê°ú À¯ÅëÀÌ ´Ê¾îÁ³½À´Ï´Ù¸¸, õ¿¬ÀÇ ¸é¿ª Áõ°Á¦³ª °Ç° ÁõÁø º¸ÃæÁ¦¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ °ü½ÉÀÌ ÇöÀúÇÏ°Ô ³ô¾ÆÁ®, ¿ì¸£¼Ö»ê ±â¹ÝÀÇ Á¦Ç° °³¹ßÀ» µÞ¹ÞħÇß½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ¿ë¸Å ÃßÃ⠺ι®ÀÌ ÃÖ´ë°¡ µÉ Àü¸Á
¼Öº¥Æ® ÃßÃ⠺ι®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ³ôÀº ÃßÃâ ¼öÀ²°ú È¿À²ÀÌ °¡´ÉÇÏ°Ô µÇ¾î, ÀǾàǰ, ÈÀåǰ, ¿µ¾ç º¸Á¶ ½Äǰ ºÐ¾ß¿¡¼ÀÇ »ó¾÷ »ý»ê¿¡ ÀûÇÕÇÕ´Ï´Ù. ¶ÇÇÑ, ¿ë¸Å ÃßÃâÀº ±× È®¸³µÈ ÇÁ·ÎÅäÄÝ, Àú·ÅÇÑ ÀåÄ¡, ƯÈ÷ °³¹ß µµ»ó±¹À̳ª Áß±Ô¸ð Á¦Á¶ ½Ã¼³¿¡¼ÀÇ ´ë·® 󸮿¡ ÀûÇÕÇϱ⠶§¹®¿¡ º¸´Ù ȯ°æ Ä£ÈÀûÀÎ ±â¼ú¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖÀ½¿¡µµ ºÒ±¸Çϰí
¿µ¾çº¸Á¶½Äǰ ºÐ¾ß´Â ¿¹Ãø±â°£ Áß °¡Àå ³ôÀº CAGRÀÌ ¿¹»óµË´Ï´Ù.
¿¹Ãø±â°£ µ¿¾È ¿µ¾çº¸Á¶½Äǰ ºÐ¾ß°¡ °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. COVID-19 ÀÌÈÄÀÇ À£´Ï½º ¹«ºê¸ÕÆ®ÀÇ °á°ú, ƯÈ÷ ³ëÀÎÀ̳ª ÇÇÆ®´Ï½º ÁöÇâÀÇ »ç¶÷µé »çÀÌ¿¡¼ ÀÌ ¿ä±¸´Â ÇÑÃþ ´õ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿¹¹æ Çコ Äɾ ¼¼°èÀûÀ¸·Î º¸±ÞµÊ¿¡ µû¶ó, ¿µ¾ç º¸Á¶ ½Äǰ ȸ»ç´Â ¿ì¸£¼Ö»êÀ» ´Ù ¼ººÐÀÇ Ã³¹æ¿¡ Ãß°¡
¿¹Ãø ±â°£ Áß ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ´Â ¿ì¸£¼Ö»êÀÌ ±âÁ¸ÀÇ ÀÇ·á¿¡ ³Î¸® ÀÀ¿ëµÇ°í ÀÖ´Â °Í, õ¿¬ °Ç° º¸ÃæÁ¦¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ´Â °Í, ÈÀåǰ ¾÷°è³ª Á¦¾à ¾÷°è°¡ ¼ºÀåÇϰí ÀÖ´Â °Í¿¡ ±âÀÎÇÕ´Ï´Ù. Áß±¹, Àεµ, ÀϺ» µîÀÇ ³ª¶óµéÀÌ ÃÖ÷´ÜÀ» ´Þ¸®°í ÀÖ½À´Ï´Ù. ¶Ç, ½ºÅ² Äɾî Á¦Ç°À̳ª ¿µ¾ç º¸Á¶ ½Äǰ¿¡ ÀÖ¾î¼, õ¿¬ ¼ººÐÀ̳ª ¿À°¡´Ð ¼ººÐÀ» ÁÁ¾ÆÇÏ´Â ¼ÒºñÀÚ°¡ ´Ã°í ÀÖ´Â °Íµµ, ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼¼°èÀÇ ¿ì¸£¼Ö»ê ½ÃÀå¿¡ ÀÖ¾î¼ÀÇ ÀÌ Áö¿ªÀÇ ¿ìÀ§¼ºÀº ´õ¿í °Ç° ÁöÇâ Áõ°¡
¿¹Ãø ±â°£ µ¿¾È À¯·´ÀÌ °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù. ÀÌ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¿ì¸£¼Ö»ê »ý»ê °øÁ¤ÀÇ È®À强°ú ºñ¿ë È¿°ú¸¦ Çâ»ó½ÃŰ´Â ÃßÃâ ±â¼úÀÇ °³¹ßÀÔ´Ï´Ù. ¿¬±¸ ¸ñÀû, ƯÈ÷ Ç×¾Ï ÀÛ¿ëÀÇ °¡´É¼ºÀ» Á¶»çÇϱâ À§ÇØ, ÀÌ ÈÇÕ¹°Àº ÇöÀ纸´Ù ½±°Ô ÀÔ¼öÇÒ ¼ö ÀÖ°Ô µÇ¾î ÀÖ½À´Ï´Ù. À¯·´ÀÇ Á¦¾à ºÎ¹®Àº ¿ì¸£¼Ö»êÀÇ Ä¡·á ¿ëµµ¸¦ Àû±ØÀûÀ¸·Î Á¶»çÇßÀ¸¸ç, ÀÌ Áö¿ª ½ÃÀåÀÇ ±Þ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¿¹Ãø ±â°£ µ¿¾È À¯·´ÀÌ ½ÃÀå ¼ºÀå·üÀ» À̲ø °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
According to Stratistics MRC, the Global Ursolic Acid Market is accounted for $376.43 million in 2025 and is expected to reach $600.51 million by 2032 growing at a CAGR of 6.9% during the forecast period. Ursolic acid is a naturally occurring compound found in the waxy coatings of various fruits, herbs, and plants, such as apples, rosemary, thyme, and basil. It is well-known for its diverse range of biological activities and is a member of the triterpene class. Because of its potential health benefits, such as its anti-inflammatory, antioxidant, anti-cancer, and antimicrobial qualities, ursolic acid has gained attention. It is also being investigated for its potential to support cardiovascular health, decrease fat accumulation, and encourage muscle growth. Moreover, these characteristics have led to ursolic acid's growing use in pharmaceutical, cosmetic, and dietary supplement formulations.
According to a comprehensive meta-analysis published in Frontiers in Pharmacology, ursolic acid (UA) significantly reduces pro-inflammatory cytokines such as IL-1B, IL-6, and TNF-a, while enhancing antioxidant enzymes like SOD and GSH. These findings suggest UA's potential in managing conditions associated with chronic inflammation and oxidative stress.
Growing interest in plant-based and natural ingredients
The market for ursolic acid is largely driven by the worldwide trend toward natural, plant-based, and sustainable ingredients. Customers are increasingly choosing botanical substitutes for synthetic chemicals in food, cosmetics, and supplement products, especially in developed nations. This requirement is perfectly met by ursolic acid, a naturally occurring triterpenoid that can be found in apple peels, rosemary, thyme, holy basil, and other herbs. Additionally, growing concerns about the sustainability of the environment and the long-term health effects of synthetic ingredients are also contributing to the trend toward a preference for naturally sourced compounds.
Insufficient solubility and low bioavailability
A major drawback of ursolic acid is that it has a low bioavailability when taken orally. Although ursolic acid has promising pharmacological qualities, it has limited absorption in the gastrointestinal tract and is poorly soluble in water. As a result, only a small portion of the active compound enters the systemic circulation, rendering it much less effective in clinical or therapeutic applications. Furthermore, new delivery methods such as liposomes, nanoparticles, and solid dispersions are being looked at to solve these issues; however, they also increase production costs and complexity, making it harder to sell these products.
Recent developments in muscle health and sports nutrition
Due to its demonstrated capacity to promote muscle growth and decrease fat mass, ursolic acid has a significant opportunity as sports nutrition and active lifestyle products gain popularity. Urosolic acid is appealing to athletes, fitness enthusiasts, and older populations looking to preserve muscle mass because studies have demonstrated that it increases IGF-1 signaling and inhibits muscle atrophy pathways. Customers who do high-intensity exercises or resistance training might also find it appealing. Moreover, ursolic acid can be positioned by manufacturers as a new plant-based performance-enhancing ingredient as the global sports nutrition market grows, especially in the U.S., Europe, and Asia-Pacific.
Strong competition from other natural substances
Strong competition from other well-known natural bioactive ingredients, like resveratrol, curcumin, quercetin, and green tea catechins, is one of the biggest risks facing the ursolic acid market. In the pharmaceutical, nutraceutical, and cosmetic industries, these substances already enjoy strong consumer trust, strong brand awareness, and solid scientific support. Compared to ursolic acid, many of them also have higher regulatory acceptance and superior bioavailability. Furthermore, product developers frequently give these alternatives top priority when it comes to formulation inclusion. Ursolic acid's market share is diminished by this fiercely competitive environment unless it can show notable and distinctive benefits in terms of efficacy, safety, or delivery systems.
The COVID-19 pandemic affected the ursolic acid market in a variety of ways. At first, production and distribution were delayed, especially for small and medium-sized manufacturers, due to labour shortages, supply chain disruptions, and restrictions on the harvesting of raw materials. However, there was a noticeable increase in consumer interest in natural immunity enhancers and health-boosting supplements as the pandemic spread, which encouraged the development of ursolic acid-based products. Due to its possible anti-inflammatory, antiviral, and muscle-preserving qualities, it gained popularity in the context of COVID-19 recovery and wellness regimens, which raised demand in the functional food and nutraceutical industries.
The solvent extraction segment is expected to be the largest during the forecast period
The solvent extraction segment is expected to account for the largest market share during the forecast period. The simplicity, affordability, and scalability of this approach make it popular for industrial applications. Ursolic acid can be efficiently extracted from natural sources such as apple peels, rosemary, and basil by employing organic solvents like ethanol or methanol. High extraction yields and efficiency are made possible by it, which makes it appropriate for commercial production in the pharmaceutical, cosmetic, and nutraceutical sectors. Moreover, solvent extraction continues to dominate despite growing interest in greener technologies due to its well-established protocols, affordable equipment, and suitability for large-volume processing, particularly in developing nations and mid-sized manufacturing facilities.
The nutraceuticals segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the nutraceuticals segment is predicted to witness the highest growth rate. The rising demand from consumers for natural, plant-based supplements that promote muscle health, weight management, and immunity is what is fueling this expansion. Ursolic acid is a common component of functional foods, capsules, and dietary supplements due to its strong anti-inflammatory and antioxidant qualities. This need has increased even more as a result of the post-COVID-19 wellness movement, particularly among older and fitness-conscious populations. Additionally, nutraceutical companies are adding ursolic acid to multi-ingredient formulas as preventive healthcare gains popularity worldwide, spurring innovation and market growth.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, driven by its widespread application in conventional medicine, rising interest in natural health supplements, and the growth of the cosmetics and pharmaceutical industries. Because of their plentiful supply of plants high in ursolic acid and their robust government support for the development of herbal products, nations like China, India, and Japan are at the forefront. Market expansion is also fueled by consumers' growing preference for natural and organic ingredients in skincare products and dietary supplements. Furthermore, the region's dominance in the global ursolic acid market is further supported by its growing health-conscious population and rising disposable income.
Over the forecast period, the Europe region is anticipated to exhibit the highest CAGR. The main factor driving this growth is the development of extraction technologies that improve the ursolic acid production process's scalability and cost-effectiveness. For research purposes, especially in examining its possible anti-cancer properties, this compound is now more easily accessible. Europe's pharmaceutical sector is actively researching the therapeutic uses of ursolic acid, which is helping the region's market grow quickly. Moreover, Europe is therefore anticipated to lead the market growth rate over the course of the forecast period.
Key players in the market
Some of the key players in Ursolic Acid Market include Hunan NutraMax Inc., Cayman Chemical Company, Inc., Acetar Bio-Tech Inc, Merck KGaA, Sabinsa Corporation, Geneham Pharmaceutical Inc, TCI Chemicals Pvt. Ltd., Changsha Staherb Natural Ingredients, Shaanxi Jintai Biological Engineering Inc and Changsha E.K HERB.
In April 2025, Merck KGaA and SpringWorks Therapeutics Inc have entered into a definitive agreement for Merck KGaA, Darmstadt, Germany, to acquire SpringWorks. The agreed acquisition of SpringWorks is a major step in our active portfolio strategy to position our company as a globally diversified, innovation and technology powerhouse.
In October 2024, Sabinsa Corporation and Postbiotics, Inc announced a multinational distribution agreement for the dietary supplement and functional food ingredient PoZibio(R) for age-related digestive health conditions including Leaky Gut Syndrome (LGS).